Who owns Skye Bioscience, Inc.?
- Ticker: SKYE
- CUSIP Number: 83086j200
Tip: Access positions for across all investors
Analyze quarterly positions in Skye Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Skye Bioscience stock
Who bought or sold Skye Bioscience, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 5AM Venture Management | 9.7M | $6.0M | 0% | Mar 2026 |
|
| Versant Venture Management | 2.0M | $1.2M | 0% | Mar 2026 |
|
| Baker Bros. Advisors | 1.6M | $968k | 9% | Mar 2026 |
|
| Vanguard Capital Management | 765k | $470k | 100% | Mar 2026 |
|
| Sphera Funds Management | 679k | $417k | 42% | Mar 2026 |
|
| BlackRock | 286k | $176k | 2% | Mar 2026 |
|
| Geode Capital Management | 277k | $171k | 32% | Mar 2026 |
|
| Millennium Management | 258k | $159k | -32% | Mar 2026 |
|
| Platinum Investment Mangement | 233k | $143k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 104k | $64k | 100% | Mar 2026 |
|
| Citadel Advisors | 99k | $61k | 20% | Mar 2026 |
|
| State Street Corporation | 75k | $46k | 0% | Mar 2026 |
|
| UBS Group | 46k | $28k | 244% | Mar 2026 |
|
| XTX Topco | 41k | $25k | -23% | Mar 2026 |
|
| Two Sigma Investments | 26k | $16k | -50% | Mar 2026 |
|
| Engineers Gate Manager | 20k | $12k | -13% | Mar 2026 |
|
| Northern Trust | 20k | $12k | 0% | Mar 2026 |
|
| Barclays | 18k | $11k | -15% | Mar 2026 |
|
| Group One Trading | 7.2k | $4.4k | -59% | Mar 2026 |
|
| Vanguard Global Advisers | 4.6k | $2.8k | 100% | Mar 2026 |
|
| Morgan Stanley | 2.5k | $1.6k | -40% | Mar 2026 |
|
| Federated Investors | 1.2k | $712.054200 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 600.00 | $364.020000 | 29900% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 400.00 | $242.000000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 127.00 | $0 | 100% | Mar 2026 |
|
| TD Waterhouse Canada | 79.00 | $51.002400 | 216% | Mar 2026 |
|
| Zurcher Kantonalbank | 52.00 | $32.000800 | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 51.00 | $30.997800 | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 39.00 | $24.000600 | 0% | Mar 2026 |
|
| Optiver Holding B.V. | 20.00 | $12.000000 | 0% | Mar 2026 |
|
| CoreCap Advisors | 8.00 | $6.000000 | 0% | Jun 2026 |
|
| Gilpin Wealth Management | 4.00 | $3.000000 | 100% | Jun 2026 |
|
| Plante Moran Financial Advisors | 3.00 | $2.000100 | 0% | Mar 2026 |
|
| Mcguire Capital Advisors | 2.00 | $1.000000 | 0% | Mar 2026 |
|
| Citigroup | 2.00 | $1.000000 | 100% | Mar 2026 |
|
| IFP Advisors | 2.00 | $1.000000 | 100% | Mar 2026 |
|
| Harbour Investments | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| PFS Partners | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| Newbridge Financial Services Group | 1.00 | $1.000000 | -94% | Mar 2026 |
|
| Leo H. Evart | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Skye Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Dec 2025 | 93k | $70k |
| Two Sigma Advisers | Dec 2025 | 41k | $31k |
| Hrt Financial | Dec 2025 | 27k | $20k |
| Jane Street | Dec 2025 | 25k | $17k |
| GSA Capital Partners | Dec 2025 | 23k | $17k |
| R Squared | Dec 2025 | 15k | $11k |
| Capital Advisors | Dec 2025 | 10k | $7.5k |
| Simplex Trading | Dec 2025 | 6.3k | $4.7k |
| FMR | Dec 2025 | 748.00 | $561.000000 |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 510.00 | $381.990000 |
| Fortitude Family Office | Dec 2025 | 385.00 | $288.981000 |
| Wells Fargo & Company | Dec 2025 | 1.00 | $1.000000 |